Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions

Published:2003-09 Issue:6 Volume:92 Page:651-655
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Kong David F,Hasselblad Vic,Harrington Robert A,White Harvey D,Tcheng James E,Kandzari David E,Topol Eric J,Califf Robert M

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa;Coller;J Clin Invest,1983

2. The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions;Knight;Mol Immunol,1995

3. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty;N Engl J Med,1994

4. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease;Kong;Circulation,1998

5. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention;Anderson;J Am Coll Cardiol,2001

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet and anticoagulation therapy during percutaneous coronary interventions: A review for the interventionalist;Journal of Interventional Cardiology;2018-06-19

2. Glycoprotein IIb/IIIa Inhibitors in Prevention and Rescue Treatment of Thromboembolic Complications During Endovascular Embolization of Intracranial Aneurysms;Neurosurgery;2017-05-03

3. Monitoring and Reversal of Anticoagulation and Antiplatelet Agents;Interventional Cardiology;2016-11-19

4. Why we need intravenous antiplatelet agents;Future Cardiology;2016-09

5. Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses;Journal of Thoracic Disease;2016-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3